SEC Company Response from CYTOKINETICS INC (CYTK) (CIK 0001061983) (CYTK) — May 15, 2019
CYTOKINETICS INC (CYTK) (CIK 0001061983)
Date: May 15, 2019 · CIK: 0001061983 · Accession: 0001193125-19-148160
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231348
Letter
Cytokinetics, Incorporated
280 East Grand Avenue
South San Francisco, CA 94080
May 15, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joseph McCann
RE: Cytokinetics, Incorporated
Registration Statement on Form S-3
File No. 333-231348
Acceleration Request
Requested Date: May 17, 2019
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective on May 17, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlton Fleming of Cooley LLP, counsel to the Registrant, at (650) 843-5865, or in his absence, Michael E. Tenta at (650) 843-5636.
Very truly yours,
Cytokinetics, Incorporated
Show Raw Text
CORRESP 1 filename1.htm CORRESP Cytokinetics, Incorporated 280 East Grand Avenue South San Francisco, CA 94080 May 15, 2019 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Joseph McCann RE: Cytokinetics, Incorporated Registration Statement on Form S-3 File No. 333-231348 Acceleration Request Requested Date: May 17, 2019 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective on May 17, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Carlton Fleming of Cooley LLP, counsel to the Registrant, at (650) 843-5865, or in his absence, Michael E. Tenta at (650) 843-5636. Very truly yours, Cytokinetics, Incorporated /s/ Ching Jaw Ching Jaw Senior Vice President, Chief Financial Officer cc: Mark A. Schlossberg, Senior Vice President, Legal and General Counsel Michael E. Tenta, Cooley LLP J. Carlton Fleming, Cooley LLP